|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 19 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2009-01-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(28,066) |
136,010 |
0 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2008-11-21 |
4 |
B |
$0.91 |
$775 |
I/I |
848 |
136,487 |
1.42 |
- |
|
BCRX |
Biocryst Pharmaceuticals ... |
10% Owner |
|
2008-11-24 |
4 |
B |
$0.98 |
$197 |
I/I |
201 |
136,688 |
1.42 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-08 |
4 |
B |
$13.28 |
$10,000 |
I/I |
753 |
136,813 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-17 |
4 |
B |
$13.28 |
$1,009 |
I/I |
76 |
136,889 |
1.42 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-12-18 |
4 |
B |
$3.56 |
$5,804 |
I/I |
1,628 |
137,183 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-18 |
4 |
B |
$9.00 |
$556,848 |
I/I |
61,872 |
137,470 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-24 |
4 |
B |
$23.43 |
$46,933 |
I/I |
2,002 |
137,598 |
2.25 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-15 |
4 |
B |
$5.66 |
$63,392 |
I/I |
11,206 |
137,687 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-25 |
4 |
B |
$23.89 |
$23,269 |
I/I |
968 |
138,566 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-12-19 |
4 |
B |
$3.60 |
$6,935 |
I/I |
1,927 |
139,110 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2009-03-02 |
4 |
B |
$2.14 |
$738 |
I/I |
343 |
139,453 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2009-03-03 |
4 |
B |
$2.14 |
$210 |
I/I |
98 |
139,551 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-22 |
4 |
B |
$8.78 |
$18,292 |
I/I |
2,084 |
139,554 |
2.17 |
- |
|
INCY |
Incyte Corp |
Director |
|
2009-03-05 |
4 |
B |
$2.16 |
$138 |
I/I |
64 |
139,615 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-28 |
4 |
B |
$25.04 |
$29,214 |
I/I |
1,164 |
139,730 |
2.25 |
- |
|
DDXS |
Diadexus Inc |
10% Owner |
|
2010-07-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
140,525 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-03-01 |
4 |
B |
$25.54 |
$30,495 |
I/I |
1,193 |
140,923 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2006-02-27 |
4 |
S |
$21.58 |
$413,293 |
I/I |
(19,030) |
140,977 |
|
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-04-17 |
4 |
S |
$15.43 |
$33,932 |
I/I |
(2,198) |
141,283 |
0 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2006-11-16 |
4 |
B |
$5.80 |
$21,912 |
I/I |
3,776 |
141,463 |
1.5 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-11-07 |
4 |
B |
$7.27 |
$5,434 |
I/I |
747 |
142,030 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2005-03-29 |
4 |
B |
$4.81 |
$36,487 |
I/I |
7,486 |
142,180 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2008-01-23 |
4 |
B |
$9.03 |
$27,490 |
I/I |
3,045 |
142,599 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2007-11-08 |
4 |
B |
$7.43 |
$6,943 |
I/I |
934 |
142,964 |
1.5 |
- |
|
1397 Records found
|
|
Page 19 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|